Shares of PTC Therapeutics Inc. (PTCT) jumped over 88% on Friday as CHMP's recommendation of the conditional marketing authorization of Translarna has removed the uncertainty over its continued availability in the European Union.
from RTT - Biotech http://ift.tt/2g6OJP3
via IFTTT
No comments:
Post a Comment